These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. In Silico Exploration of Aryl Halides Analogues as Checkpoint Kinase 1 Inhibitors by Using 3D QSAR, Molecular Docking Study, and ADMET Screening. Ghaleb A; Aouidate A; Bouachrine M; Lakhlifi T; Sbai A Adv Pharm Bull; 2019 Feb; 9(1):84-92. PubMed ID: 31011562 [No Abstract] [Full Text] [Related]
32. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone. Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR Comput Biol Chem; 2018 Aug; 75():178-195. PubMed ID: 29883916 [TBL] [Abstract][Full Text] [Related]
33. A computer-aided drug design approach to explore novel type II inhibitors of c-Met receptor tyrosine kinase for cancer therapy: QSAR, molecular docking, ADMET and molecular dynamics simulations. Daoui O; Nour H; Abchir O; Elkhattabi S; Bakhouch M; Chtita S J Biomol Struct Dyn; 2023; 41(16):7768-7785. PubMed ID: 36120976 [TBL] [Abstract][Full Text] [Related]
34. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations. Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817 [TBL] [Abstract][Full Text] [Related]
35. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities, Alam MS; Lee DU Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310 [TBL] [Abstract][Full Text] [Related]
36. Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents. Azad I; Nasibullah M; Khan T; Hassan F; Akhter Y J Mol Graph Model; 2018 May; 81():211-228. PubMed ID: 29609141 [TBL] [Abstract][Full Text] [Related]
37. Structure-based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation, and Metabolic Reactivity Studies of Quinazoline Derivatives for their Anti-EGFR Activity Against Tumor Angiogenesis. Shah AA; Ahmad S; Yadav MK; Raza K; Kamal MA; Akhtar S Curr Med Chem; 2024; 31(5):595-619. PubMed ID: 36892124 [TBL] [Abstract][Full Text] [Related]
38. Benzothiazole derivatives as p53-MDM2 inhibitors: N SD; Shivakumar ; Kumar D U; Ghate SD; Dixit SR; Awasthi A; Revanasiddappa BC J Biomol Struct Dyn; 2023 Dec; ():1-12. PubMed ID: 38111168 [TBL] [Abstract][Full Text] [Related]
40. Exploring the interaction between epidermal growth factor receptor tyrosine kinase and some of the synthesized inhibitors using combination of Nasab RR; Mansourian M; Hassanzadeh F; Shahlaei M Res Pharm Sci; 2018 Dec; 13(6):509-522. PubMed ID: 30607149 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]